| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Karuna Therapeutics Inc (NASDAQ: KRTX)
KRTX Technical Analysis
4
| As on 9th Jun 2023 KRTX STOCK Price closed @ 227.62 and we RECOMMEND Buy for LONG-TERM with Stoploss of 155.83 & Strong Buy for SHORT-TERM with Stoploss of 114.49 we also expect STOCK to react on Following IMPORTANT LEVELS. |
KRTXSTOCK Price
| Open | 233.47 | Change | Price | % |
| High | 234.80 | 1 Day | -6.20 | -2.65 |
| Low | 227.42 | 1 Week | 1.07 | 0.47 |
| Close | 227.62 | 1 Month | 35.66 | 18.58 |
| Volume | 284800 | 1 Year | 104.86 | 85.42 |
| 52 Week High 277.42 | 52 Week Low 93.97 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| KRTX Daily Charts |
KRTX Intraday Charts |
Whats New @ Bazaartrend |
KRTX Free Analysis |
|
|
KRTX Important Levels Intraday
| RESISTANCE | 241.84 |
| RESISTANCE | 237.28 |
| RESISTANCE | 234.46 |
| RESISTANCE | 231.64 |
| SUPPORT | 223.60 |
| SUPPORT | 220.78 |
| SUPPORT | 217.96 |
| SUPPORT | 213.40 |
KRTX Forecast May 2024
| 4th UP Forecast | 289.38 |
| 3rd UP Forecast | 269.57 |
| 2nd UP Forecast | 257.33 |
| 1st UP Forecast | 245.09 |
| 1st DOWN Forecast | 210.15 |
| 2nd DOWN Forecast | 197.91 |
| 3rd DOWN Forecast | 185.67 |
| 4th DOWN Forecast | 165.86 |
KRTX Weekly Forecast
| 4th UP Forecast | 245.83 |
| 3rd UP Forecast | 239.99 |
| 2nd UP Forecast | 236.38 |
| 1st UP Forecast | 232.77 |
| 1st DOWN Forecast | 222.47 |
| 2nd DOWN Forecast | 218.86 |
| 3rd DOWN Forecast | 215.25 |
| 4th DOWN Forecast | 209.41 |
KRTX Forecast2024
| 4th UP Forecast | 586.02 |
| 3rd UP Forecast | 471.08 |
| 2nd UP Forecast | 400.03 |
| 1st UP Forecast | 328.98 |
| 1st DOWN Forecast | 126.26 |
| 2nd DOWN Forecast | 55.21 |
| 3rd DOWN Forecast | -15.84 |
| 4th DOWN Forecast | -130.78 |
Karuna Therapeutics Inc ( NASDAQ USA Symbol : KRTX )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
KRTX Business Profile
Karuna Therapeutics, Inc., a clinical-stage biopharmaceutical company, creates and delivers transformative medicines for people living with psychiatric and neurological conditions. Its lead product candidate is KarXT, an oral modulator of muscarinic receptors that has completed Phase II clinical trial for the treatment of acute psychosis in patients with schizophrenia; and in Phase Ib clinical trial for the treatment of central nervous system disorders, such as negative and cognitive symptoms of schizophrenia and psychosis, as well as for the treatment of dementia-related psychosis. The company also focuses on developing other muscarinic-targeted drug candidates. Karuna Therapeutics, Inc. has a license agreement with Eli Lilly and Company; patent license agreement with PureTech Health LLC; and drug discovery partnership with Charles River Laboratories, as well as drug discovery collaboration with PsychoGenics, Inc. The company was formerly known as Karuna Pharmaceuticals, Inc. and changed its name to Karuna Therapeutics, Inc. in March 2019. Karuna Therapeutics, Inc. was incorporated in 2009 and is headquartered in Boston, Massachusetts. Address: 33 Arch Street, Boston, MA, United States, 02110
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service